Inactivation and recovery in Kv1.4 K+ channels: Lipophilic interactions at the intracellular mouth of the pore

Journal of Physiology

Volumn 556, Issue 1, 2004, Pages 109-120

  Bett, Glenna C L ^a   Rasmusson, Randall L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; POTASSIUM ION; QUINIDINE; VALINE; VOLTAGE GATED POTASSIUM CHANNEL; KCSA CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.4; UNCLASSIFIED DRUG;

ALLOSTERISM; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE PERMEABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HYDROPHOBICITY; LIPOPHILICITY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEADY STATE; X RAY CRYSTALLOGRAPHY; XENOPUS LAEVIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; BINDING AFFINITY; MOLECULAR DYNAMICS; POINT MUTATION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN INTERACTION;

ALANINE; ALLOSTERIC REGULATION; AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CYTOPLASM; FEMALE; GENE DELETION; INTRACELLULAR FLUID; KV1.4 POTASSIUM CHANNEL; MOLECULAR CONFORMATION; OOCYTES; PEPTIDE FRAGMENTS; PERMEABILITY; POINT MUTATION; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; QUINIDINE; VALINE; XENOPUS LAEVIS;

EID: 1942517931     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2003.055012     Document Type: Article

References (50)

1. Adelman JP, Bond CT, Pessia M & Maylie J (1995). Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 15, 1449-1454.
2. Aldrich RW, Hoshi T & Zagotta WN (1990). Differences in gating among amino-terminal variants of Shaker potassium channels. Cold Spring Harbor Symposia Quantitative Biol 55, 19-27.
3. +-induced anomalous recification in squid giant axons. J General Physiol 50, 491-503.
4. Armstrong CM (1968). Induced inactivation of the potassium permeability of squid axon membranes. Nature 219, 1262-1263.
5. Armstrong CM (1969). Inactivation of the potassium conductance and related phenomena caused by quaternary ammonium ion injection in squid axons. J General Physiol 54, 553-575.
6. Armstrong CM (1971). Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons. J General Physiol 58, 413-437.
7. Barry DM & Nerbonne JM (1996). Myocardial potassium channels: electrophysiological and molecular diversity. Ann Rev Physiol 58, 363-394.
8. +]: a tale of two inactivation mechanisms. Neuron 15, 951-960.
9. + channels. Proc Nat Acad Sci 93, 13357-13361.
10. Bett GCL & Rasmusson RL (2003). Functionally-distinct proton-binding in HERG suggests the presence of two binding sites. Cell Biochem Biophys 39, 183-194.
11. Busch AE, Hurst RS, North RA, Adelman JP & Kavanaugh MP (1991). Current inactivation involves a histidine residue in the pore of the rat lymphocyte potassium channel RGK5. Biochem Biophys Res Comm 179, 1384-1390.
12. Caballero R, Moreno I, Gonzalez T, Valenzuela C, Tamargo J & Delpon E (2002). Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5). Cardiovasc Res 56, 104-117.
13. Castle NA, Fadous SR, Logothetis DE & Wang GK (1994). 4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels. Mol Pharmacol 46, 1175-1181.
14. Chen J, Seebohm G & Sanguinetti MC (2002). Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels. Proc Natl Acad Sci 99, 12461-12466.
15. + channels. Proc Nat Acad Sci 88, 5092-5095.
16. + channel kv1.4 by acidosis: protonation of an extracellular histidine slows the recovery from N-type inactivation. J Physiol 526, 253-264.
17. Comer MB, Campbell DL, Rasmusson RL, Lamson DR, Morales MJ, Zhang Y & Strauss HC (1994). Cloning and characterization of an Ito-like potassium channel from ferret ventricle. Am J Physiol 267, H1383-H1395.
18. + channel behaves like an open-channel blocker. Neuron 7, 743-753.
19. + channels. Mol Pharmacol 60, 1343-1348.
20. + channels. Circ Res 82, 386-395.
21. + channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ Res 79, 669-675.
22. Heginbotham L & MacKinnon R (1992). The aromatic binding site for tetraethylammonium ion on potassium channels. Neuron 8, 483-491.
23. + channel. J General Physiol 108, 195-206.
24. Hoshi T, Zagotta WN & Aldrich RW (1990). Biophysical and molecular mechanisms of Shaker potassium channel inactivation. Science 250, 533-538.
25. + channels: effects of alterations in the carboxy-terminal region. Neuron 7, 547-556.
26. + channel. Nature 353, 86-90.
27. + channel inactivation mediated by the concerted action of the cytoplasmic N- and C-terminal domains. Biophys J 72, 163-174.
28. + channels expressed in Xenopus oocytes. J Physiol 549, 683-695.
29. i in rat ventricular myocytes following myocardial infarction. J Physiol 517, 229-245.
30. Kiehn J, Lacerda AE, Wible B & Brown AM (1996). Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide. Circulation 94, 2572-2579.
31. Lee JK, Nishiyama A, Kambe F, Seo H, Takeuchi S, Kamiya K, Kodama I & Toyama J (1999). Downregulation of voltage-gated K(+) channels in rat heart with right ventricular hypertrophy. Am J Physiol 277, H1725-H1731.
32. +: evidence for transmembrane communication. Am J Physiol) 284, H71-H80.
33. Lipkind GM, Hanck DA & Fozzard HA (1995). A structural motif for the voltage-gated potassium channel pore. Proc Nat Acad Sci 92, 9215-9219.
34. + channel during gating. Neuron 16, 859-867.
35. + channel comprises part of the pore. Nature 367, 179-182.
36. Lopez-Barneo J, Hoshi T, Heinemann SH & Aldrich RW (1993). Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. Receptors Channels 1, 61-71.
37. Mitcheson JS, Chen J, Lin M, Culberson C & Sanguinetti MC (2000). A structural basis for drug-induced long QT syndrome. Proc Nat Acad Sci 97, 12329-12333.
38. + channel beta subunit increases the rate of C-type inactivation from the cytoplasmic side of the channel. Proc Nat Acad Sci 93, 15119-15123.
39. + channel gene expression in diabetic rat ventricle: isoform switching between Kv4.2 and Kv1.4. Am J Physiol 281, H1800-H1807.
40. + channel (Kv1.4) expressed in Xenopus oocytes. J Physiol 489, 709-721.
41. + channels. Circ Res 82, 739-750.
42. + channel block. J Biol Chem 277, 23587-23595.
43. Kr potassium channel. Cell 81, 299-307.
44. Snyders DJ & Chaudhary A (1996). High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol 49, 949-955.
45. Wang S, Liu S, Morales MJ, Strauss HC & Rasmusson RL (1997a). A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes. J Physiol 502, 45-60.
46. +]o and C-type inactivation. FEBS Lett 417, 43-47.
47. Wang S, Morales MJ, Qu YJ, Bett GC, Strauss HC & Rasmusson RL (2003). Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect. J Physiol 546, 387-401.
48. + channel. Role of S6 in antiarrhythmic drug binding. Circulation Res 78, 1105-1114.
49. Zagotta WN, Hoshi T & Aldrich RW (1990). Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB. Science 250, 568-571.
50. Zhou M, Morais-Cabral JH, Mann S & MacKinnon R (2001). Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors. Nature 411, 657-661.